|
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM …
MarketWatch (press release) Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European … Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM … |
View full post on asthma – Google News